Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Buy

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Kezar Life Sciences, Inc. Common Stock (KZR)

Pharmaceutical Preparations

https://www.kezarlifesciences.com

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as KZR-616, and the protein secretion program.

4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO, CA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/21/2018

Market Cap

45,805,669

Shares Outstanding

72,800,000

Weighted SO

72,800,000

Total Employees

N/A

Upcoming Earnings

08/08/2024

Similar Tickers

IPSC --.--%

MLYS --.--%

NKTX --.--%

NGM --.--%

SRZN --.--%

BOLT --.--%

LRMR --.--%

KROS --.--%

LYEL --.--%

Beta

0.2750

Last Div

0.0000

Range

0.54-1.69

Chg

0.0032

Avg Vol

598675

Mkt Cap

45805669

Exch

NASDAQ

Country

US

Phone

650 822 5600

DCF Diff

-0.8799

DCF

1.4900

Div Yield

0.0000

P/S

29.1385

EV Multiple

-0.3559

P/FV

0.3035

Div Yield %

0.0000

P/E

-0.4640

PEG

0.0105

Payout

0.0000

Current Ratio

9.5809

Quick Ratio

9.5809

Cash Ratio

1.6162

DSO

391.4695

DIO

0.0000

Op Cycle

391.4695

DPO

765.5190

CCC

-374.0495

Gross Margin

0.3136

Op Margin

-63.3212

Pretax Margin

-62.7023

Net Margin

-62.7023

Eff Tax Rate

0.0070

ROA

-0.5478

ROE

-0.5450

ROCE

-0.6128

NI/EBT

1.0000

EBT/EBIT

0.9902

EBIT/Rev

-63.3212

Debt Ratio

0.0748

D/E

0.0893

LT Debt/Cap

0.0479

Total Debt/Cap

0.0820

Int Coverage

-49770.5000

CF/Debt

-5.8759

Equity Multi

1.1940

Rec Turnover

0.9324

Pay Turnover

0.4768

Inv Turnover

0.0000

FA Turnover

0.2719

Asset Turnover

0.0087

OCF/Share

-1.0856

FCF/Share

-1.0874

Cash/Share

2.2538

OCF/Sales

-50.3041

FCF/OCF

1.0017

CF Coverage

-5.8759

ST Coverage

-13.4738

CapEx Coverage

-577.2117

Div&CapEx Cov

-577.2117

P/BV

0.3035

P/B

0.3035

P/S

29.1385

P/E

-0.4640

P/FCF

-0.5782

P/OCF

-0.5783

P/CF

-0.5783

PEG

0.0105

P/S

29.1385

EV Multiple

-0.3559

P/FV

0.3035

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jun 13, 21:30 MacKenzie Realty Capital Secures $3 Million Loan for Non-Traded REIT Shares Benzinga Sep 27, 21:55 MacKenzie Realty Capital, Inc. Announces 3?? quarter dividend GlobeNewswire Inc. Sep 27, 21:55 MacKenzie Realty Capital, Inc. Announces 3?? quarter dividend

Revenue Product Segmentation